DECHANTSREITER, MICHAEL A.,GROB, JONATHAN E.,MAC SWEENEY, AENGUS,MILTZ, WOLFGANG,RANDL, STEFAN,SEDRANI, RICHARD,SELLNER, HOLGER,SIROCKIN, FINTON,VALEUR, ERIC
申请号：
CA2877526
公开号：
CA2877526A1
申请日:
2013.06.19
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The present invention provides a compound of formula I a method for manufacturing the compounds of the invention, and its therapeutic uses as inhibitor of the complement alternative pathway and particularly as inhibitor of Factor B for the treatment of e.g. age-related macular degeneration and diabetic retinopathy. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
